|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2010-8-10
|
|
pubmed:abstractText |
Accurate quantification of tumour tracer uptake is essential for therapy monitoring by sequential PET imaging. In this study we investigated to what extent a reduction in administered activity, synonymous with an overall reduction in repeated patient exposure, compromised the accuracy of quantitative measures using time-of-flight PET/CT.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1619-7089
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1643-53
|
|
pubmed:dateRevised |
2011-1-5
|
|
pubmed:meshHeading |
pubmed-meshheading:20428866-Adult,
pubmed-meshheading:20428866-Humans,
pubmed-meshheading:20428866-Neoplasms,
pubmed-meshheading:20428866-Phantoms, Imaging,
pubmed-meshheading:20428866-Positron-Emission Tomography,
pubmed-meshheading:20428866-Reproducibility of Results,
pubmed-meshheading:20428866-Time Factors,
pubmed-meshheading:20428866-Tomography, X-Ray Computed,
pubmed-meshheading:20428866-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Time-of-flight PET/CT using low-activity protocols: potential implications for cancer therapy monitoring.
|
|
pubmed:affiliation |
Department of Nuclear Medicine, Barts and The London School of Medicine, West Smithfield (QE II), London, UK.
|
|
pubmed:publicationType |
Journal Article
|
